Rybelsus vs. Ozempic

Key Takeaways

Ozempic Formulation: Ozempic is currently available as an injectable medication for managing Type 2 Diabetes. It does not come in pill form, but a similar oral medication, Rybelsus, contains the same active ingredient (semaglutide) and offers an alternative for those who prefer not to use injections.

Rybelsus Vs. Ozempic: Both Rybelsus (oral semaglutide) and Ozempic (injectable semaglutide) are used to manage blood sugar levels in individuals with Type 2 Diabetes. While they share the same active ingredient, their administration methods, dosage options, and absorption rates differ.

Effectiveness & Considerations: Ozempic and Rybelsus are effective for controlling blood sugar and promoting weight loss, but Ozempic’s injectable form may provide more consistent results due to higher bioavailability. Rybelsus, as a pill, might be a more convenient option for some patients but requires strict timing around meals for optimal absorption.

Choosing the Right Option: The decision between Ozempic and Rybelsus should be made based on individual preferences, medical history, and specific health needs. Consulting with a healthcare provider can help determine the most suitable treatment plan for Diabetes management.

What Is Ozempic?

Ozempic (semaglutide) is a brand-name prescription medication that was FDA-approved in 2017 for the treatment of Type 2 Diabetes and related cardiovascular disease in adults over the age of 18. It is manufactured by Novo Nordisk.

Usage

Ozempic is a once-weekly medication administered via subcutaneous injection to the abdomen, thigh, or upper arm. It comes in pre-filled, single-patient-use injection pens and must be refrigerated before being opened and carefully disposed of after its expiration date.

Dosage

Ozempic comes in the following doses:

• 0.25 mg
• 0.5 mg
• 1 mg
• 2 mg

Ozempic is started at an initial, non-therapeutic dose of 0.25 mg for four weeks before being increased to 0.5 mg per week. Four weeks after starting the 0.5 mg dose, a doctor will evaluate whether or not further dose increases are necessary, to a maximum of 2 mg per week. Gradually increasing Ozempic’s dose over time helps the body adjust to the new medication and can help to reduce side effects.

Does Ozempic Come In Pill Form?

There isn’t a direct and simple yes or no answer to this question. That’s because Ozempic’s active ingredient, semaglutide, is available in pill form under the brand name Rybelsus. That being said, Rybelsus isn’t exactly the same as Ozempic.

Like Ozempic, Rybelsus is approved for blood sugar management in adults with Type 2 Diabetes. But there are some key differences, namely:

• Ozempic comes in 0.25 mg, 0.5 mg, 1 mg, and 2 mg doses; Rybelsus comes in 3 mg, 7 mg, and 14 mg doses.
• Ozempic is injected subcutaneously once weekly; Rybelsus is taken orally once daily, usually first thing in the morning at least 30 minutes before eating.
• Ozempic is indicated for the treatment of Type 2 Diabetes in adults as well as for the reduction of major adverse cardiovascular events in patients with Type 2 Diabetes and established cardiovascular disease; Rybelsus is only indicated for the treatment of Type 2 Diabetes.

Ozempic and Rybelsus are both associated with weight loss in diabetic populations, but neither is approved as a weight loss drug (though either may be prescribed off-label for this purpose if the prescribing physician feels it will benefit a particular patient).

Wegovy, which is identical to Ozempic but injected at a higher maintenance dose of 2.4 mg per week, is associated with more significant weight loss and has been approved for chronic weight management in obese and overweight populations since 2021. Rybelsus is not the same as Wegovy, but recent clinical trials have examined whether oral semaglutide medications could be associated with weight loss outcomes similar to Wegovy at higher doses.

What Is Rybelsus?

Rybelsus (semaglutide) is a brand-name prescription medication that was FDA-approved in 2019 for the treatment of Type 2 Diabetes in adults over 18 years of age. It is manufactured by Novo Nordisk.

Usage

Rybelsus is a once-daily oral medication that’s taken in pill form. It must be taken on an empty stomach first thing in the morning with no more than 4 oz. of water and at least 30 minutes before eating breakfast or taking any other medications.

Rybelsus should be stored at room temperature in a dry place. It must be kept in its original container and not combined with other medications or added to a pill organizer.

Dosage

Rybelsus tablets come in the following dosages:

• 3 mg
• 7 mg
• 14 mg

Patients usually start taking Rybelsus at the 3 mg dosage for 30 days. After that, they increase to the 7 mg dosage for another 30 days. At that point, a medical assessment helps to determine whether or not increasing to the maximum dose of 14 mg per day is warranted. Gradually increasing the amount of Rybelsus over time allows the body time to adjust to the new medication and often helps to decrease the overall impact of side effects.

What Are The Main Differences Between Ozempic & Rybelsus?

Ozempic and Rybelsus both contain the active ingredient semaglutide and are essentially different versions of the same drug. The main differences between them are:

• Method of Delivery – Ozempic is delivered once weekly via subcutaneous injection; Rybelsus is taken orally in tablet form once daily.
• Dosage – Ozempic’s dosage ranges from 0.25 to 2 mg weekly; Rybelsus’s dosage ranges from 3 mg to 14 mg daily.
• Indication – Ozempic treats Type 2 Diabetes and related cardiovascular disease in adults; Rybelsus treats Type 2 Diabetes in adults.

Are Ozempic & Rybelsus Equally Effective?

This question requires a two-part answer:

If we’re just talking about the ability to lower blood sugar levels in patients with Type 2 Diabetes, then yes. Though no head-to-head research trial has directly compared the two drugs, extensive clinical studies of Ozempic and Rybelsus on their own have found that both drugs are similarly effective for blood sugar management in combination with diet and exercise.

That being said, while research indicates that Rybelsus is safe for patients with heart problems, Ozempic has actually been shown to reduce the risk of serious cardiovascular outcomes in patients with Type 2 Diabetes and heart disease. In this respect, Ozempic is the more effective drug.

Who Are Good Candidates For Ozempic?

Ozempic is a suitable option for adults with Type 2 Diabetes who need additional help managing their blood sugar levels, particularly if they are already using other medications like metformin without achieving the desired results. It is also a good choice for those who prefer a once-weekly injection and may benefit from Ozempic’s additional weight-loss effects. However, individuals with a history of certain medical conditions, such as thyroid cancer or pancreatitis, should avoid using Ozempic and discuss alternative treatments with their healthcare provider.

Who Are Good Candidates For Rybelsus?

Rybelsus may be an appropriate choice for people with Type 2 Diabetes who are looking for an oral medication rather than an injectable option to help control their blood sugar. It is particularly suited for individuals who may not be comfortable with self-injections or prefer a daily pill as part of their routine. However, strict adherence to taking Rybelsus on an empty stomach is necessary for optimal effectiveness, so patients who can commit to this regimen may benefit the most. Those with a history of thyroid cancer or severe gastrointestinal issues should consult their doctor before considering Rybelsus.

Can Ozempic & Rybelsus Be Used For Weight Loss?

Because semaglutide decreases appetite, slows down the digestive process, and often causes gastrointestinal symptoms, it’s often associated with weight loss. Indeed, many Type 2 Diabetes patients report losing weight easily while taking both Rybelsus and Ozempic. Research corroborates these reports.

Neither Ozempic nor Rybelsus is officially indicated for weight loss, though they may be prescribed off-label for this purpose at the discretion of a medical professional.

Wegovy, a third semaglutide drug manufactured by Novo Nordisk, was FDA-approved for chronic weight management in adults in 2021 and teens over the age of 12 in 2022. Like Ozempic, Wegovy is an injectable medication with a higher maximum dose of semaglutide (2.4 mg). It’s indicated for patients who are obese or overweight and suffer from at least one weight-related health condition.

Which Drug Is Better For Weight Loss?

As mentioned above, neither Ozempic nor Rybelsus is indicated for weight loss. That fact aside, research suggests that patients typically lose more weight on Ozempic than on Rybelsus. Ozempic’s clinical trials for weight loss ultimately led to the approval of Wegovy as a weight loss drug.

How Much Weight Can You Lose With Rybelsus & Ozempic?

Both Rybelsus and Ozempic have been shown to help with weight loss in addition to managing blood sugar levels in people with Type 2 Diabetes. Studies suggest that people taking Ozempic may lose an average of 9 to 12 pounds over a period of 6 to 12 months, while those on Rybelsus might experience a weight loss of around 5 to 8 pounds during the same timeframe. The amount of weight loss can vary depending on factors like diet, exercise, and individual response to the medication. Although neither medication is specifically approved for weight loss, the potential reduction in body weight can be an added benefit for many patients.

Ozempic & Rybelsus Side Effects

Because Ozempic and Rybelsus both contain semaglutide, their potential side effects are very similar. For both drugs, most side effects are mild and often resolve over time.

Common mild side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Injection site reactions (Ozempic only)

Though rare, more serious side effects can also occur with both Rybelsus and Ozempic. Speak with your doctor or seek medical care immediately if you experience any of the following:

• Pancreatitis
• Acute gallbladder disease
• Severe low blood sugar (hypoglycemia)
• Vision changes (Diabetic retinopathy)
• Severe allergic reactions
• Acute kidney problems

Both medications come with a black box warning regarding the potential development of thyroid C-cell tumors. The development of thyroid tumors was documented in animal studies of semaglutide but hasn’t been studied in humans. It’s not recommended to take Ozempic or Rybelsus if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Type 2 (MENS2).

Ozempic and Rybelsus shouldn’t be taken if you’re pregnant, breastfeeding, or planning to become pregnant.

Conclusion

To conclude, Rybelsus and Ozempic are both semaglutide-based drugs produced by Novo Nordisk and are indicated for lowering blood sugar levels in adult patients with Type 2 Diabetes. In addition, Ozempic helps lower the risk of major cardiovascular events in patients with both Type 2 Diabetes and heart disease.

While Ozempic is an injectable medication taken once weekly, Rybelsus is an oral medication taken once daily in tablet form. Neither drug has been approved for weight management, but both have been associated with healthy weight loss when complemented with lifestyle changes such as exercise and a healthy, calorie-deficient diet. Wegovy, an injectable semaglutide medication that comes in a slightly higher dose than Ozempic, has been approved by the FDA for chronic weight management in obese and overweight individuals.

If your doctor has recommended Ozempic as a treatment option for you and you’re looking for an affordable way to source the drug, Bisonpharmacy.com may be the perfect solution. We provide high-quality Canadian Ozempic to customers across the U.S. and are committed to exceptionally prompt and professional service.

For more information about how to order Ozempic online from Canada, contact Bisonpharmacy.com today!